Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente research scientist and yoga teacher Ai Kubo harnesses a popular smartphone app to fulfill her longtime goal of spreading the benefits of mindfulness scientifically.
Partners of people with newly diagnosed diabetes are more likely to improve their health behaviors than partners of people without the disease, according to a large new Kaiser Permanente study published today in Annals of Family Medicine.
The Division of Research's Douglas Corley will be responsible for developing and implementing a new research program in The Permanente Medical Group that will advance the creation of evidence-driven strategies to improve the delivery of health care.
For patients with type 2 diabetes in usual practice, the use of the more expensive insulin analogs did not appear to result in better safety or better blood sugar control compared with NPH insulin.
Neurologists of the Kaiser Permanente Northern California Stroke FORCE team get clot-busting alteplase to patients twice as fast as the national average.
DOR's Theodore (TR) Levin, MD, is one of four recipients of The Permanente Medical Group's 2018 Sidney R. Garfield Exceptional Contribution Awards, for pioneering efforts to expand colorectal cancer screening.
Technology allows a panel of urologists and oncologists to provide the most up-to-date treatment for every single person with testicular cancer at Kaiser Permanente Northern California.
Over a 10-year period, control of three key cardiovascular risk factors improved faster for Kaiser Permanente diabetes patients in Northern California than in the rest of the United States, according to research published in the American Journal of Medicine.
The second Cardiovascular Research Symposium drew approximately 80 people including researchers, sub-specialty physicians, quality and operational staff, and others from across Kaiser Permanente’s Northern California region. It was convened at the Division of Research (DOR) in Oakland by Alan S. Go, MD, DOR’s associate director of Cardiovascular and Metabolic Conditions Research.
A new study shows that a treatment regimen of 8 weeks for hepatitis C may be just as effective as 12 weeks in black patients. The study also showed that more people overall can take advantage of the shorter treatment durations, which has important implications for access given the medication’s high cost.